David H. Harpole

19.9k total citations · 3 hit papers
203 papers, 12.8k citations indexed

About

David H. Harpole is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, David H. Harpole has authored 203 papers receiving a total of 12.8k indexed citations (citations by other indexed papers that have themselves been cited), including 157 papers in Pulmonary and Respiratory Medicine, 60 papers in Oncology and 52 papers in Surgery. Recurrent topics in David H. Harpole's work include Lung Cancer Diagnosis and Treatment (101 papers), Lung Cancer Treatments and Mutations (75 papers) and Esophageal Cancer Research and Treatment (31 papers). David H. Harpole is often cited by papers focused on Lung Cancer Diagnosis and Treatment (101 papers), Lung Cancer Treatments and Mutations (75 papers) and Esophageal Cancer Research and Treatment (31 papers). David H. Harpole collaborates with scholars based in United States, United Kingdom and Japan. David H. Harpole's co-authors include Thomas A. D’Amico, James E. Herndon, Mark W. Onaitis, William R. Burfeind, Mark F. Berry, Betty C. Tong, Eric M. Toloza, Walter G. Wolfe, Rebecca P. Petersen and David J. Sugarbaker and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

David H. Harpole

200 papers receiving 12.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups

2008 690 citations Gary M. Strauss, James E. Herndon et al. Journal of Clinical Oncology profile →
Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: A propensity-matched analysis from the STS database

2010 586 citations Nasser K. Altorki, David H. Harpole et al. Journal of Thoracic and Cardiovascular Surgery profile →
Reporting and Guidelines in Propensity Score Analysis: A Systematic Review of Cancer and Cancer Surgical Studies

2017 266 citations David H. Harpole, Mark F. Berry et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
David H. Harpole	9.1k	3.8k	3.3k	1.5k	1.1k	203	12.8k
Robert J. Downey	7.0k 0.8×	3.4k 0.9×	3.2k 1.0×	1.5k 1.0×	1.2k 1.0×	201	11.3k
Walter Weder	9.7k 1.1×	3.0k 0.8×	3.9k 1.2×	2.6k 1.7×	1.5k 1.3×	434	15.4k
Joe B. Putnam	11.2k 1.2×	4.2k 1.1×	5.0k 1.5×	2.0k 1.3×	911 0.8×	202	14.9k
Rodney J. Landreneau	11.3k 1.2×	2.8k 0.7×	7.6k 2.3×	1.8k 1.2×	1.9k 1.6×	345	17.8k
Ara A. Vaporciyan	7.5k 0.8×	2.5k 0.7×	4.9k 1.5×	1.4k 0.9×	778 0.7×	322	11.4k
Sarah Burdett	5.3k 0.6×	3.6k 1.0×	1.9k 0.6×	1.3k 0.8×	1.3k 1.2×	56	9.8k
Donna Hollis	4.6k 0.5×	5.9k 1.6×	3.0k 0.9×	1.8k 1.1×	1.3k 1.1×	154	11.4k
Peter Goldstraw	11.6k 1.3×	5.3k 1.4×	2.6k 0.8×	2.4k 1.5×	1.3k 1.1×	169	14.8k
Thomas A. D’Amico	8.7k 1.0×	2.5k 0.7×	3.7k 1.1×	1.2k 0.8×	579 0.5×	299	11.1k
Garrett L. Walsh	6.8k 0.7×	1.9k 0.5×	5.4k 1.6×	1000 0.6×	1.0k 0.9×	238	10.4k

Countries citing papers authored by David H. Harpole

Since Specialization

Citations

This map shows the geographic impact of David H. Harpole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David H. Harpole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David H. Harpole more than expected).

Fields of papers citing papers by David H. Harpole

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David H. Harpole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David H. Harpole. The network helps show where David H. Harpole may publish in the future.

Co-authorship network of co-authors of David H. Harpole

This figure shows the co-authorship network connecting the top 25 collaborators of David H. Harpole. A scholar is included among the top collaborators of David H. Harpole based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David H. Harpole. David H. Harpole is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Heymach, John V., David H. Harpole, Tetsuya Mitsudomi, et al.. (2023). Abstract CT005: AEGEAN: A phase 3 trial of neoadjuvant durvalumab + chemotherapy followed by adjuvant durvalumab in patients with resectable NSCLC. Cancer Research. 83(8_Supplement). CT005–CT005. 55 indexed citations

Worrell, Stephanie G., Karyn A. Goodman, Nasser K. Altorki, et al.. (2023). The Society of Thoracic Surgeons/American Society for Radiation Oncology Updated Clinical Practice Guidelines on Multimodality Therapy for Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction. The Annals of Thoracic Surgery. 117(1). 15–32. 5 indexed citations

Reck, Martin, Daniel P. Gale, David H. Harpole, et al.. (2023). LBA59 Associations of ctDNA clearance and pathological response with neoadjuvant treatment in patients with resectable NSCLC from the phase III AEGEAN trial. Annals of Oncology. 34. S1300–S1300. 23 indexed citations

Fudim, Marat, Yawar J. Qadri, Nathan H. Waldron, et al.. (2020). Stellate Ganglion Blockade for the Treatment of Refractory Ventricular Arrhythmias. JACC. Clinical electrophysiology. 6(5). 562–571. 53 indexed citations

Raman, Vignesh, Oliver K. Jawitz, Chi‐Fu Jeffrey Yang, et al.. (2019). Outcomes of surgery versus chemoradiotherapy in patients with clinical or pathologic stage N3 non–small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery. 158(6). 1680–1692.e2. 9 indexed citations

Raman, Vignesh, Oliver K. Jawitz, Chi‐Fu Jeffrey Yang, et al.. (2019). The influence of adjuvant therapy on survival in patients with indeterminate margins following surgery for non–small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery. 159(5). 2030–2040.e4. 3 indexed citations

Crowson, Matthew G., Betty C. Tong, Hui‐Jie Lee, et al.. (2018). Prevalence and resource utilization for vocal fold paralysis/paresis after esophagectomy. The Laryngoscope. 128(12). 2815–2822. 4 indexed citations

Yi, John S., Neal Ready, Patrick Healy, et al.. (2017). Immune Activation in Early-Stage Non–Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab. Clinical Cancer Research. 23(24). 7474–7482. 62 indexed citations

Boyer, Matthew J., Christina D. Williams, David H. Harpole, et al.. (2017). Improved Survival of Stage I Non–Small Cell Lung Cancer: A VA Central Cancer Registry Analysis. Journal of Thoracic Oncology. 12(12). 1814–1823. 29 indexed citations

10.

Berry, Mark F., Mathias Worni, Xiaofei Wang, et al.. (2013). Sleeve Lobectomy for Non-Small Cell Lung Cancer With N1 Nodal Disease Does Not Compromise Survival. The Annals of Thoracic Surgery. 97(1). 230–235. 19 indexed citations

11.

Erhunmwunsee, Loretta, et al.. (2012). Neighborhood‐level socioeconomic determinants impact outcomes in nonsmall cell lung cancer patients in the Southeastern United States. Cancer. 118(20). 5117–5123. 59 indexed citations

12.

DʼAlonzo, Richard C., Elliott Bennett‐Guerrero, Mihai V. Podgoreanu, et al.. (2011). A randomized, double blind, placebo controlled clinical trial of the preoperative use of ketamine for reducing inflammation and pain after thoracic surgery. Journal of Anesthesia. 25(5). 672–678. 17 indexed citations

13.

Strauss, Gary M., James E. Herndon, Michael A. Maddaus, et al.. (2008). Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. Journal of Clinical Oncology. 26(31). 5043–5051. 690 indexed citations breakdown →

14.

Burfeind, William R., Betty C. Tong, Erin E. O’Branski, et al.. (2008). Quality of life outcomes are equivalent after lobectomy in the elderly. Journal of Thoracic and Cardiovascular Surgery. 136(3). 597–604. 52 indexed citations

15.

Atkins, B. Zane, et al.. (2007). Pulmonary Segmentectomy by Thoracotomy or Thoracoscopy: Reduced Hospital Length of Stay With a Minimally-Invasive Approach. The Annals of Thoracic Surgery. 84(4). 1107–1113. 130 indexed citations

16.

Kinch, Michael S., et al.. (2003). Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival.. PubMed. 9(2). 613–8. 199 indexed citations

17.

Harpole, David H., et al.. (1995). A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression.. PubMed. 55(1). 51–6. 252 indexed citations

18.

Harpole, David H., Jeffrey R. Marks, William G. Richards, James E. Herndon, & David J. Sugarbaker. (1995). Localized adenocarcinoma of the lung: Oncogene expression of erbB-2 and p53 in 150 patients. Lung Cancer. 13(3). 331–332. 62 indexed citations

19.

Harpole, David H., et al.. (1992). Analysis of 945 cases of pulmonary metastatic melanoma. Journal of Thoracic and Cardiovascular Surgery. 103(4). 743–750. 150 indexed citations

20.

Harpole, David H. & Robert H. Jones. (1990). Serial assessment of ventricular performance after valve replacement for aortic stenosis. Journal of Thoracic and Cardiovascular Surgery. 99(4). 645–650. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact